Semler Scientific Aims to Hold 105,000 Bitcoins by 2027

Semler Scientific, Inc. has unveiled an ambitious three-year plan to substantially increase its Bitcoin holdings. The company aims to hold 10,000 Bitcoins by the end of 2025, 42,000 by the end of 2026, and ultimately 105,000 Bitcoins by the end of 2027. The funds for this acquisition will be sourced from equity and debt financings, as well as operational cash flows. This initiative highlights Semler Scientific's commitment to Bitcoin as its primary treasury reserve asset, positioning the company as a leading corporate holder of the cryptocurrency.

The appointment of Joe Burnett as the Director of Bitcoin Strategy further strengthens Semler Scientific's dedication to this strategy. Burnett, a well-known figure in the Bitcoin community, brings extensive experience and analytical insights to the role. His expertise will be crucial in driving the company's three-year plan to accumulate 105,000 Bitcoins. Burnett's background includes serving as the Director of Market Research at Unchained, where he contributed to the broader adoption of Bitcoin in capital markets. He has also been a thought leader on the rise of Bitcoin treasury companies, hosting top macro and Bitcoin thinkers on various podcasts.

Semler Scientific's adoption of Bitcoin as its primary treasury reserve asset began in May 2024, making it the second U.S. publicly traded company to do so. Since then, the company has achieved significant gains, with an approximate 287% BTC Yield and a $177 million BTC Gain through June 3, 2025. This success is attributed to a strong team and growing connections within the Bitcoin community, which have enabled the company to accelerate its Bitcoin accumulation strategy.

The company's strategic plan to hold 105,000 Bitcoins by the end of 2027 is a bold move that reflects its long-term conviction in Bitcoin as the ultimate long-duration asset. This strategy is expected to deliver long-term value to stockholders, as Semler Scientific aims to build one of the largest corporate Bitcoin treasuries in the world. The company's commitment to this strategy is further evidenced by its plans to use proceeds from equity and debt financings, as well as operational cash flows, to support this acquisition.

Semler Scientific's decision to adopt Bitcoin as its primary treasury reserve asset is part of a broader trend of companies recognizing the value of Bitcoin as a superior form of money. This trend is accelerating, with more corporations adopting Bitcoin as part of their treasury strategies. Semler Scientific's leadership in this movement positions the company at the forefront of this trend, with a clear vision for the future of corporate treasury management.

In addition to its Bitcoin strategy, Semler Scientific is also a pioneer in developing and marketing technology products and services to assist in evaluating and treating chronic diseases. Its flagship product, QuantaFlo®, is a rapid point-of-care test that measures arterial blood flow in the extremities, aiding in the diagnosis of cardiovascular diseases such as peripheral arterial disease (PAD). The company is seeking a new 510(k) clearance for expanded indications, further solidifying its position as a leader in healthcare technology.